Aptus Pharma IPO
Aptus Pharma is a BSE SME IPO listed on the BSE SME platform, priced at ₹65–₹70 per share. The stock debuted at ₹80.8, delivering a listing gain of 15.4%. The IPO had a lot size of ₹2000 shares and a minimum investment of ₹1,40,000.
Aptus Pharma Limited IPO
- IPO Dates
- Sep 23, 2025 – Sep 25, 2025
- Price band
- ₹65-70 per equity share
- Minimum Investment
- ₹1,40,000
- Issue size
- ₹13.02 Cr
- Lot size
- 2000
- Allotment Date
- Sep 26, 2025
- Listing
- Sep 30, 2025
- Listing At
- BSE SME
IPO timeline
-
Sep 23, 2025
Open Date
Completed
-
Sep 25, 2025
Close Date
Completed
-
Sep 26, 2025
Allotment Date
Completed
-
Sep 30, 2025
Listing Date
Completed
Aptus Pharma IPO Subscription Details
View Subscription DetailsAptus Pharma IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Aptus Pharma IPO Essentials
Aptus Pharma IPO Details
Aptus Pharma IPO is priced at ₹65-70 per share with a total issue size of 13.02 crore. The IPO has a lot size of 2000 shares and is listed on BSE SME.
- Issue price
- ₹65-70 per equity share
- Lot size
- 2000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 18,60,000 shares (aggregating up to ₹13.02 Cr)
#Fresh Issue: 18,60,000 shares (aggregating up to ₹13.02 Cr) - Total issue size
- 18,60,000 shares
(aggregating up to ₹13.02 crore) - Fresh issue
- 18,60,000 shares
(aggregating up to ₹13.02 crore) - Listing at
- BSE SME
- List price
- 80.80
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
Interactive Financial Services Ltd.
Market Lot Size
Investors can bid for a minimum of 4,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 2 | 4,000 | ₹2,80,000 |
| Retail(max) | 2 | 4,000 | ₹2,80,000 |
| sHNI(min) | 3 | 6,000 | ₹4,20,000 |
| sHNI(max) | 7 | 14,000 | ₹9,80,000 |
| sHNI(min) | 8 | 16,000 | ₹11,20,000 |
Aptus Pharma IPO Reservation
Aptus Pharma IPO reservation details show category-wise allocation of shares. Out of the total 18,60,000 shares, approximately 18.92% are reserved for QIB, 14.3% for NII, 33.33% for retail investors, 5.05% for market maker, and 28.39% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 5,28,000 (28.39%) | |
| Market Maker Shares Offered | 94,000 (5.05%) | |
| QIB Shares Offered | 3,52,000 (18.92%) | |
| NII (HNI) Shares Offered | 2,66,000 (14.3%) | |
| bHNI > ₹10L | 178,000 (9.6%) | 30 |
| sHNI < ₹10L | 88000 (4.81%) | 15 |
| Retail Shares Offered | 6,20,000 (33.33%) | 155 |
| Total Shares Offered | 18,60,000 (100%) |
Aptus Pharma IPO Analytics
Aptus Pharma IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Aptus Pharma IPO Subscription Status
Aptus Pharma IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 22.4x, indicating strong demand across investor categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 3,52,000 / 2,66,000 | 6,20,000 | 12,38,000 |
|
Day 1
23-09-25 06:00 PM
|
(0.00 / 4.78) x | 1.77 x | 1.92 x |
|
Day 2
24-09-25 06:00 PM
|
(0.81 / 6.16) x | 5.46 x | 4.29 x |
|
Day 3
25-09-25 06:00 PM
|
(1.24 / 28.75) x | 31.43 x | 22.27 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 5555 (Approx) | 10.87x | 22.53x | 31.54x |
Aptus Pharma Valuations
Earnings
- EPS Pre IPO
- ₹6.20
- EPS Post IPO
- ₹4.52
- P/E Pre IPO
- 11.29
- P/E Post IPO
- 15.49
Returns
- ROE
- 44.50%
- ROCE
- 45.66%
- RoNW
- 44.50%
Fundamentals
- Debt / Equity
- 1.49
Aptus Pharma Financials( In Crs.)
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 21.92 | 10.03 | 6.22 |
| Revenue | 24.64 | 17.88 | 13.90 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Reserves & Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowing | 10.36 | 5.31 | 2.21 |
Aptus Pharma Company & Offer Insights
About Aptus Pharma
Established in 2010, Aptus Pharma Ltd is a company dealing with marketing, and distribution of finished pharmaceutical formulations. The company deals with manufacturers and distributors of a wide range of pharmaceutical formulations catering to various therapeutic categories: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, etc. Products: Aptus Pharma: Deals with acute therapies i.e, anti-infectives, pain management, etc. Aptus CD care: Deals with chronic therapies. Aptus Wellcare: Wellness and nutraceutical products. Aptus Global: Export in overseas market. The company has 194 formulations of medicines in over eleven therapeutic segments as of March 31, 2025. Its warehouse is spread over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model has 125 direct and sub distributors and a sales force of 54 field staff. The company had 70 employees as of March 31, 2025.
Aptus Pharma Promoter(s)
Tejash Maheshchandra Hathi, Chatrabhuj Vallabhbhai Butani, Kapilbhai Hasmukhbhai Chandarana, Ghanshyam Vinubhai Pansuriya, Milly Chetan Lalseta, Riddhish Natwarlal Tanna, Gaurang Rameshchandra Thakker, Kripaliben Mayank Thakker, Kunjal Piyushbhai Unadkat are the company's promoters of Aptus Pharma.
Aptus Pharma IPO Issue Objectives
- •
- Capital Expenditure for Office Premises with furniture and Industrial Racks - ₹1.63 Cr
- •
- Working Capital - ₹8.00 Cr
- •
- General corporate purposes
Contact Information
Contact Details
Aptus Pharma
+91 76004 27827
Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427
Registrar Contact Details
Bigshare Services Pvt.Ltd.
+91-22-6263 8200
Frequently Asked Questions
Click any question to reveal the answer
Aptus Pharma IPO is a book-built IPO worth ₹13.02 crore. The price band is ₹65–₹70 per share. The IPO opens on Sep 23, 2025 and closes on Sep 25, 2025. It will be listed on BSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The price band of Aptus Pharma IPO is ₹65 to ₹70 per share.
The lot size of Aptus Pharma IPO is 2000 shares.
The minimum investment for Aptus Pharma IPO is approximately ₹1,40,000 based on the upper price band .
Aptus Pharma IPO opens on Sep 23, 2025 and closes on Sep 25, 2025.
The allotment date of Aptus Pharma IPO is Sep 26, 2025.
Aptus Pharma IPO is expected to be listed on Sep 30, 2025, on BSE SME Platform.
Aptus Pharma IPO valuation snapshot: P/E 15.49, EPS ₹4.52, P/B N/A, RoNW 44.50%, and market cap N/A.
To apply for Aptus Pharma IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Aptus Pharma IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Aptus Pharma IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Aptus Pharma IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Aptus Pharma IPO allotment status on IPO Ji for quick and easy access.